Active Cells, Biochemistry & Physiology Diabetes, Hormones & Metabolism

Mechanisms of selective protein secretion: towards therapeutic interventions.

In plain English

AI plain-English summary

Every cell in the body acts as a factory, packaging specific proteins into tiny bubbles for export—but how it chooses which proteins to ship out remains poorly understood. This project tackles that fundamental gap: the molecular machinery that selects certain proteins for secretion from the endoplasmic reticulum, the cell’s protein-sorting hub. The researchers aim to map exactly how two medically relevant cargo receptors grab hold of their protein passengers, then find small molecules that can block those handshakes. If successful, the work would provide a molecular blueprint for selectively shutting down secretion of harmful proteins—for instance, those that drive inflammation, fibrosis, or tumour growth—without disrupting the cell’s general export system. This is fundamental science with a clear translational hook: the tool compounds developed here could become starting points for a new class of drugs that dial down specific disease-causing secretions. The research does not promise a therapy tomorrow, but it addresses a core biological question—how cells maintain selectivity amid molecular chaos—that has direct implications for any condition where protein over-secretion is the problem.

View original technical description
Protein secretion is an essential process that delivers a diverse array of proteins to the extracellular milieu. We study the conserved cellular machinery that mediates the first step of protein secretion, export from the endoplasmic reticulum. We aim to understand how cells maintain selectivity when handling a vast diversity of protein sequence and structure. Here, we aim to dissect the molecular mechanisms by which cargo proteins are selectively captured into nascent vesicles. We then aim to leverage redundancy in this step to specifically abrogate a subset of interactions using small molecules, thereby inhibiting secretion of a subset of proteins. Our aims encompass a blend of mechanistic studies that dissect protein-protein interactions for two export receptors, chosen for their conservation and medical relevance (Aims 1 and 2), complemented by cell-based approaches to reveal the spectrum of proteins that engage these machineries in diverse cell types (Aim 3), and small molecule screens for modulators of these interactions (Aim 4). At the completion of our studies, I anticipate having a molecular understanding of how key medically important cargoes engage their receptors, how such interactions drive unique secretion signatures in diverse cells, and a set of tool compounds that perturb interactions to impact secretion.

View the original record at the funder ↗

Researchers

Liz Miller (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Selective packaging of proteins for secretion via COPII vesicles
Obtaining a molecular understanding of antibody secretion
Elucidating the pathways and machinery of constitutive secretion
14-3-3 Dependent targeting of K2P channels: A fundamental pathway for the intracellular vesicular trafficking of cell surface membrane proteins
Secretory protein folding, modification and the unfolded protein response

Original classification

Discovery Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.